# CIMBAR PERFORMANCE MINERALS, INC. – FDA Inspection, Feb 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/b77e5690-fd3f-485b-822a-d341a4f029fa
Source feed: FDA_Inspections

> FDA inspection 1005647 of CIMBAR PERFORMANCE MINERALS, INC., February 03, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 211, 212 and 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005647
- Company Name: CIMBAR PERFORMANCE MINERALS, INC.
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1275942 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/50586038-4649-43d8-9313-9b860c41325a)
- FDA Inspection 1120887 - 2020-01-30
- FDA Inspection 924339 - 2015-04-30

## Related Officers

- [Company Rep](https://www.keypedia.com/people/larry-k-hampton/de10767b-b25b-4d55-bfe2-60ea51c828f6)

Company: https://www.keypedia.com/companies/cimbar-performance-minerals-inc/de097cdd-af46-4d14-8566-45a6205d9895

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
